Mecamylamine Pill
Phase 1Small molecule
Mecamylamine Pill is one of 6 small molecule programs targeting Attention. It is currently in Phase 1.
1
Indications
3
Total Trials
1
Active Trials
5
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
6 competitors in Attention
#DrugCompanyPhaseTrials
1Ritalin
NovartisApproved
Tractocile
GSKPhase 1
Minipress
PfizerPreclinical
Pitressin
AAultman Health Foundation
Preclinical
Oxytocin Treatment
UUniversity of Electronic Science and Technology of China
Phase 1
Mecamylamine Pill
VVanderbilt University Medical Center
Phase 1
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Mecamylamine Pill. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details